Target intelligence / Profile preview

RNA, U6 small nuclear 882, pseudogene (RNU6-882P)

Target
RNU6-882P
Molecular classification
Other, Pseudogene, Processed pseudogene
01

Overview

RNU6-882P (RNA, U6 small nuclear 882, pseudogene) is a human pseudogene related to U6 small nuclear RNA, a key component of the spliceosome responsible for intron removal from pre-mRNA in eukaryotes[1][5]. While the canonical U6 snRNA plays an essential and evolutionarily conserved role in RNA splicing, the RNU6-882P locus is a non-functional, non-coding sequence and is not transcribed into a functional RNA or protein[1]. There is no evidence that RNU6-882P itself acts as a receptor, enzyme, transporter, or any therapeutic target, nor is it associated with disease modulation or used as a biomarker. The existence of many U6 pseudogenes in the genome suggests past retrotransposition events and highlights the critical evolutionary importance of the U6 snRNA gene[5]. Key points: - RNU6-882P does not produce functional RNA or protein. - It is not a drug target, therapeutic receptor, or a disease biomarker. - No known direct biological or disease-related function is described for RNU6-882P[1][2][5]. Available scientific data indicate it is a genomic annotation as a pseudogene only, with no current therapeutic or clinical significance.

Other names
RNU6-882P
02

Biological functions

No demonstrated biological function (as a pseudogene)Pseudogenes in general can sometimes regulate gene expression post-transcriptionally by acting as competing endogenous RNAs or through antisense interactions, but specific functions for RNU6-882P are not established
03

Disease associations

Other (no known direct association with disease; U6-related pseudogenes as a class do not currently have well-defined disease associations)

Beyond the preview

Go deeper on RNA, U6 small nuclear 882, pseudogene (RNU6-882P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 882, pseudogene (RNU6-882P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call